Take-home messages from the 2nd COPD 2023 Biennial of the French Society of Respiratory Diseases. Placing the patient at the center of the care pathway
Copyright © 2024 SPLF. Published by Elsevier Masson SAS. All rights reserved..
INTRODUCTION: The second COPD Biennial organized by the COPD working group of the French Society of Respiratory Diseases took place in Paris (Cochin) on 13th December 2023.
STATE OF THE ART: Major trends in 2023 were discussed; they encompassed concepts, definitions, biologics, care pathways, pulmonary rehabilitation and complex situations entailed by respiratory infections, cardiovascular comorbidities and pulmonary hypertension, and modalities of oxygen therapy and ventilation.
PERSPECTIVES: The different talks underlined major changes in COPD including the concepts of pre-COPD, etiotypes, health trajectories and new definitions of exacerbation. Recent results in biologics for COPD open the door to new pharmacological options. Assessment of current care pathways in France highlighted some causes for concern. For example, pulmonary rehabilitation is a key but insufficiently practiced element. Respiratory infections require careful assessment and treatments. Diagnosis and treatment of cardiovascular comorbidities and pulmonary hypertension are of paramount importance. As of late, oxygen therapy and ventilation modalities have evolved, and are beginning to afford more personalized options.
CONCLUSIONS: As regards COPD, a personalized approach is crucial, placing the patient at the center of the care pathway and facilitating coordination between healthcare providers.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Revue des maladies respiratoires - (2024) vom: 11. Apr. |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Principaux messages de la deuxième Biennale BPCO 2023 de la SPLF. Le patient au cœur du parcours de soins |
|---|
| Beteiligte Personen: |
Ancel, J [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 12.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.rmr.2024.03.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370990757 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370990757 | ||
| 003 | DE-627 | ||
| 005 | 20240413233139.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240413s2024 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.rmr.2024.03.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1374.xml |
| 035 | |a (DE-627)NLM370990757 | ||
| 035 | |a (NLM)38609767 | ||
| 035 | |a (PII)S0761-8425(24)00174-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Ancel, J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Take-home messages from the 2nd COPD 2023 Biennial of the French Society of Respiratory Diseases. Placing the patient at the center of the care pathway |
| 246 | 3 | 3 | |a Principaux messages de la deuxième Biennale BPCO 2023 de la SPLF. Le patient au cœur du parcours de soins |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 12.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024 SPLF. Published by Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a INTRODUCTION: The second COPD Biennial organized by the COPD working group of the French Society of Respiratory Diseases took place in Paris (Cochin) on 13th December 2023 | ||
| 520 | |a STATE OF THE ART: Major trends in 2023 were discussed; they encompassed concepts, definitions, biologics, care pathways, pulmonary rehabilitation and complex situations entailed by respiratory infections, cardiovascular comorbidities and pulmonary hypertension, and modalities of oxygen therapy and ventilation | ||
| 520 | |a PERSPECTIVES: The different talks underlined major changes in COPD including the concepts of pre-COPD, etiotypes, health trajectories and new definitions of exacerbation. Recent results in biologics for COPD open the door to new pharmacological options. Assessment of current care pathways in France highlighted some causes for concern. For example, pulmonary rehabilitation is a key but insufficiently practiced element. Respiratory infections require careful assessment and treatments. Diagnosis and treatment of cardiovascular comorbidities and pulmonary hypertension are of paramount importance. As of late, oxygen therapy and ventilation modalities have evolved, and are beginning to afford more personalized options | ||
| 520 | |a CONCLUSIONS: As regards COPD, a personalized approach is crucial, placing the patient at the center of the care pathway and facilitating coordination between healthcare providers | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Biological therapy | |
| 650 | 4 | |a Biothérapie | |
| 650 | 4 | |a Bronchopneumopathie chronique obstructive | |
| 650 | 4 | |a Chronic obstructive | |
| 650 | 4 | |a Comorbidity | |
| 650 | 4 | |a Comorbidité | |
| 650 | 4 | |a Médecine de précision | |
| 650 | 4 | |a Physiopathologie | |
| 650 | 4 | |a Physiopathology | |
| 650 | 4 | |a Precision medicine | |
| 650 | 4 | |a Pulmonary disease | |
| 700 | 1 | |a Chen, E |e verfasserin |4 aut | |
| 700 | 1 | |a Pavot, A |e verfasserin |4 aut | |
| 700 | 1 | |a Regard, L |e verfasserin |4 aut | |
| 700 | 1 | |a Le Rouzic, O |e verfasserin |4 aut | |
| 700 | 1 | |a Guecamburu, M |e verfasserin |4 aut | |
| 700 | 1 | |a Zysman, M |e verfasserin |4 aut | |
| 700 | 1 | |a Rapin, A |e verfasserin |4 aut | |
| 700 | 1 | |a Martin, C |e verfasserin |4 aut | |
| 700 | 1 | |a Soumagne, T |e verfasserin |4 aut | |
| 700 | 1 | |a Patout, M |e verfasserin |4 aut | |
| 700 | 1 | |a Roche, N |e verfasserin |4 aut | |
| 700 | 1 | |a Deslee, G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revue des maladies respiratoires |d 1988 |g (2024) vom: 11. Apr. |w (DE-627)NLM012622443 |x 1776-2588 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:11 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rmr.2024.03.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 11 |c 04 | ||